STOCK TITAN

IBEX director sells 5,522 shares at $40.10

A director of IBEX Ltd reported a September 2026 open-market share sale, reducing his direct holdings to 2,813 common shares.

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

IBEX Ltd (IBEX) director Zhuang Mingzhe reported selling 5,522 common shares on September 15, 2026 in an open-market or private transaction at a weighted average price of $40.10 per share, with individual trade prices ranging from $39.82 to $40.39. After this sale, Zhuang held 2,813 common shares directly. No Rule 10b5-1 trading plan is reported for this transaction.

Positive

  • None.

Negative

  • None.
Insider Zhuang Mingzhe
Role Director
Sold 5,522 shs ($221K)
Type Security Shares Price Value
Sale Common Shares F1 5,522 $40.1022 $221K
Holdings After Transaction: Common Shares — 2,813 shares (Direct)
Footnotes (1)
  1. F1. This transaction was executed in multiple trades at prices ranging from $39.82 to $40.39; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Shares sold 5,522 shares Common shares sold by director on September 15, 2026
Weighted average sale price $40.10 per share Weighted average for 5,522 shares sold, trades from $39.82 to $40.39
Shares held after transaction 2,813 shares Director’s direct IBEX common share holdings after the sale
Net buy/sell shares 5,522 shares sold Net selling activity reported in this Form 4
weighted average sales price financial
"the price reported above reflects the weighted average sales price"
open market or private transaction financial
"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for director Zhuang Mingzhe?

IBEX reported that director Zhuang Mingzhe sold 5,522 common shares on September 15, 2026 in a sale classified as an open-market or private transaction.

At what price were the IBEX (IBEX) shares sold in this Form 4?

The filing reports a weighted average sales price of $40.10 per share for the 5,522 shares sold, with individual trade prices ranging from $39.82 to $40.39.

How many IBEX (IBEX) shares does the director hold after the reported sale?

After the sale reported on September 15, 2026, director Zhuang Mingzhe directly holds 2,813 common shares of IBEX Ltd.

Was the IBEX (IBEX) insider sale made under a Rule 10b5-1 trading plan?

The Form 4 indicates that the Rule 10b5-1 checkbox is not marked, so no Rule 10b5-1 trading plan is reported in connection with this sale.

Does the IBEX (IBEX) Form 4 provide details on the trade price breakdown?

Yes. A footnote states the 5,522 shares were sold in multiple trades at prices between $39.82 and $40.39, and that full trade-by-trade information will be provided upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zhuang Mingzhe

(Last)(First)(Middle)
C/O IBEX LIMITED
1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)
WASHINGTON DISTRICT OF COLUMBIA 20006

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares09/15/2026S5,522D$40.1022(1)2,813D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $39.82 to $40.39; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Remarks:
Lisa Lenstrohm, Attorney-in-Fact09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading